136 related articles for article (PubMed ID: 12695690)
21. Activin A induction of cell-cycle arrest involves modulation of cyclin D2 and p21CIP1/WAF1 in plasmacytic cells.
Yamato K; Koseki T; Ohguchi M; Kizaki M; Ikeda Y; Nishihara T
Mol Endocrinol; 1997 Jul; 11(8):1044-52. PubMed ID: 9212052
[TBL] [Abstract][Full Text] [Related]
22. Effects of PC-SPES on proliferation and expression of AR/PSA in androgen-responsive LNCaP cells are independent of estradiol.
Hsieh TC; Xiong W; Traganos F; Darzynkiewicz Z; Wu JM
Anticancer Res; 2002; 22(4):2051-60. PubMed ID: 12174883
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
24. Phenylacetate inhibits growth and modulates cell cycle gene expression in renal cancer cell lines.
Franco OE; Onishi T; Umeda Y; Soga N; Wakita T; Arima K; Yanagawa M; Sugimura Y
Anticancer Res; 2003; 23(2B):1637-42. PubMed ID: 12820434
[TBL] [Abstract][Full Text] [Related]
25. Unique natural antioxidants (NAOs) and derived purified components inhibit cell cycle progression by downregulation of ppRb and E2F in human PC3 prostate cancer cells.
Bakshi S; Bergman M; Dovrat S; Grossman S
FEBS Lett; 2004 Aug; 573(1-3):31-7. PubMed ID: 15327971
[TBL] [Abstract][Full Text] [Related]
26. Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors.
Mir H; Kapur N; Singh R; Sonpavde G; Lillard JW; Singh S
Cell Cycle; 2016; 15(6):819-26. PubMed ID: 27029529
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of action of herbal supplement PC-SPES: elucidation of effects of individual herbs of PC-SPES on proliferation and prostate specific gene expression in androgen-dependent LNCaP cells.
Hsieh TC; Wu JM
Int J Oncol; 2002 Mar; 20(3):583-8. PubMed ID: 11836572
[TBL] [Abstract][Full Text] [Related]
28. Doenjang hexane fraction-induced G1 arrest is associated with the inhibition of pRB phosphorylation and induction of Cdk inhibitor p21 in human breast carcinoma MCF-7 cells.
Choi YH; Choi BT; Lee WH; Rhee SH; Park KY
Oncol Rep; 2001; 8(5):1091-6. PubMed ID: 11496322
[TBL] [Abstract][Full Text] [Related]
29. Herbal therapy PC-SPES: in vitro effects and evaluation of its efficacy in 69 patients with prostate cancer.
de la Taille A; Buttyan R; Hayek O; Bagiella E; Shabsigh A; Burchardt M; Burchardt T; Chopin DK; Katz AE
J Urol; 2000 Oct; 164(4):1229-34. PubMed ID: 10992371
[TBL] [Abstract][Full Text] [Related]
30. Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s).
Narayanan BA; Condon MS; Bosland MC; Narayanan NK; Reddy BS
Clin Cancer Res; 2003 Aug; 9(9):3503-13. PubMed ID: 12960143
[TBL] [Abstract][Full Text] [Related]
31. Apoptosis and modulation of cell cycle control by synthetic derivatives of ursodeoxycholic acid and chenodeoxycholic acid in human prostate cancer cells.
Choi YH; Im EO; Suh H; Jin Y; Yoo YH; Kim ND
Cancer Lett; 2003 Sep; 199(2):157-67. PubMed ID: 12969788
[TBL] [Abstract][Full Text] [Related]
32. Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21(/WAF1/CIP1).
Srivastava RK; Chen Q; Siddiqui I; Sarva K; Shankar S
Cell Cycle; 2007 Dec; 6(23):2953-61. PubMed ID: 18156803
[TBL] [Abstract][Full Text] [Related]
33. Equiguard suppresses androgen-dependent LNCaP prostate cancer cell proliferation by targeting cell cycle control via down regulation of the retinoblastoma protein Rb and induction of apoptosis via the release of cytochrome c.
Lu X; Hsieh TC; Wu JM
Int J Oncol; 2004 Dec; 25(6):1801-7. PubMed ID: 15547720
[TBL] [Abstract][Full Text] [Related]
34. Effects of a phytotherapeutic agent, PC-SPES, on prostate cancer: a preliminary investigation on human cell lines and patients.
de la Taille A; Hayek OR; Buttyan R; Bagiella E; Burchardt M; Katz AE
BJU Int; 1999 Nov; 84(7):845-50. PubMed ID: 10532984
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21(Waf1) and p27(Kip1).
Marra DE; Simoncini T; Liao JK
Circulation; 2000 Oct; 102(17):2124-30. PubMed ID: 11044431
[TBL] [Abstract][Full Text] [Related]
36. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells.
Schmidt M; Fan Z
Oncogene; 2001 Sep; 20(43):6164-71. PubMed ID: 11593424
[TBL] [Abstract][Full Text] [Related]
37. Ionizing radiation and teniposide increase p21(waf1/cip1) and promote Rb dephosphorylation but fail to suppress E2F activity in MCF-7 breast tumor cells.
Orr MS; Watson NC; Sundaram S; Randolph JK; Jain PT; Gewirtz DA
Mol Pharmacol; 1997 Sep; 52(3):373-9. PubMed ID: 9281598
[TBL] [Abstract][Full Text] [Related]
38. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
[TBL] [Abstract][Full Text] [Related]
39. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells.
Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH
Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery.
Jensen SS; Madsen MW; Lukas J; Binderup L; Bartek J
Mol Endocrinol; 2001 Aug; 15(8):1370-80. PubMed ID: 11463860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
